Lexeo Therapeutics, Inc.

Nasdaq:LXEO

Biological Products, (No Diagnostic Substances)·NEW YORK, NY

Governanceproxy statements · beneficial ownership

Proxy Statements

5 shown

Filed	Form	Description
6/5/25	DEFA14A	DEFA14A	→
4/28/25	DEFA14A	DEFA14A	→
4/28/25	DEF 14A	DEF 14A	→
4/26/24	DEFA14A	DEFA14A	→
4/26/24	DEF 14A	DEF 14A	→

Ownership Filings

40 shown

Filed	Form	Description
2/20/26	4	4	→
2/20/26	4/A	4/A	→
2/20/26	4	4	→
2/17/26	4	4	→
2/6/26	4	4	→
2/6/26	4	4	→
↓